Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Mid Atlantic Bio Angels
AddedFeb 15, 2024
UpdatedJun 28, 2026
Mid Atlantic Bio Angels

Mid Atlantic Bio Angels

Operating

MABA: A US-based venture capital firm specializing in life science investments.

Location
New York City, NY, US
Founded
2012
Firm
Compare
Portfolio
Employees
Website

Investments

Astrocyte Pharmaceuticals
Astrocyte Pharmaceuticals

Total Raised

$31.9M

Rounds

11

Series B$6MAugust 2023
Series A$6MMay 2021
Hilltop Biosciences
Hilltop Biosciences

Total Raised

$3.3M

Rounds

5

AngelMarch 2023
New View Surgical
New View Surgical

Total Raised

$28.1M

Rounds

9

Series B$9MNovember 2021
Series A$2.1MJune 2019
Series A$2.5MMarch 2017
Seneca Therapeutics
Seneca Therapeutics

Total Raised

$7.7M

Rounds

3

Series UnknownMay 2021
Sana Health
Sana Health

Total Raised

$22.6M

Rounds

19

SeedNovember 2020
Healionics
Healionics

Total Raised

$19.4M

Rounds

11

Series Unknown$3MFebruary 2019
Virion Therapeutics
Virion Therapeutics

Total Raised

$14.1M

Rounds

6

Series A$5MSeptember 2018
Elysium Therapeutics
Elysium Therapeutics

Total Raised

$1.6M

Rounds

5

Series UnknownDecember 2017
Opsidio
Opsidio

Total Raised

$500k

Rounds

1

Series Unknown$500kSeptember 2017
PainQx
PainQx

Total Raised

$3.8M

Rounds

5

Seed$1.6MAugust 2017
Genome Profiling
Genome Profiling

Total Raised

$1.1M

Rounds

4

Series UnknownNovember 2016
Evrys Bio
Evrys Bio

Total Raised

$34.8M

Rounds

5

Series UnknownJune 2016
Immunomic Therapeutics
Immunomic Therapeutics

Total Raised

$75.4M

Rounds

8

Series Unknown$3MOctober 2013